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Background: The excessive and unwarranted consumption of antibiotics is the leading factor 
in promoting the spread of antimicrobial resistant (AMR), which is considered to be a potential 
major threat to global public health and economic growth. Several systematic reviews have 
been published exploring the pattern of antibiotic use in the Middle East and low-and middle-
income countries without including studies from Egypt. Because of the strategic importance of 
Egypt as the most populated country in the Middle East and the largest producer of health 
workers in the area, a systematic review focusing on the situation in Egypt is timely and useful. 
Objective: Investigating the problem of self-medication and non-prescription dispensing of 
antibiotics in Egypt and suggesting interventions that could fit in the Egyptian context. 
Methods: A thorough search was done across databases (Medline, ProQuest and Scopus) using 
MeSH terms and regular keywords generated from the research question. The Inclusion and 
Exclusion criteria were applied, and the included studies were critically appraised using NOS. 
Results: The review included 10 studies after screening processes. The aggregate rate was 46% 
for self-medication with antibiotics and 76% for dispensing of antibiotics without prescription. 
Financial issues, time-consuming doctor visits and the lack of strict regulations were the 
leading reasons for such high rates. β-lactam antibiotics were the most used antibiotic class. 
Discussion: The prevalence of over-the-counter use and dispensing of antibiotics is quite high 
in Egypt, with serious consequences nationally and globally, which call for taking corrective 
actions. Awareness campaigns for public and health personnel and the enforcement of strict 
regulations are straightforward and effective interventions.  
Conclusion: Intense international efforts are essential to control the inappropriate antibiotic-
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1.0. Introduction and Background 
For more than 90 years, since Sir Alexander Fleming discovered penicillin (Fleming, 1980), 
antibiotics have been side by side with humans supporting their immune systems in their vital 
fight against pathogenic microbes. However, this defense arrangement has become weaker and 
weaker as a result of the growing spread of antibiotic-resistant bacteria. Generally speaking, 
bacteria are living microorganisms that exists in nature with a huge variety of strains with 
different characteristics, and a wide range of them could be pathogenic for humans and animals. 
A very important characteristic of bacteria is that they are organisms that evolve quickly to 
respond to challenges, as over the years, they were able to develop different mechanisms and 
enzymes that made them able to protect themselves against the effect of antibiotics as well as 
other threats in nature and pass these genes across new generations. It is noteworthy that this 
is exactly what Sir Fleming warned about in his acceptance speech for Nobel Prize in Medicine 
1945, as he stressed on the fact that microbes could easily become resistant to penicillin as a 
result of using it wrong (Fleming, 1945). 
The discovery of penicillin and the further development of the wide range of effective 
antimicrobials has brought about a medical revolution in treating and controlling the spread of 
several communicable diseases. A unique success story is the crucial role that the successively 
developed antibiotics and antibiotic-combinations have been playing in the treatment of 
tuberculosis since the discovery of the cause of tuberculosis by Robert Koch in 1882 and until 
present time (Murray, Schraufnagel, & Hopewell, 2015).  
As a result of the increasing spread of antibiotic-resistant bacteria, humans seem to be losing 
their critical advantage over bacteria in this “micro-war”, and here is exactly where the problem 
lies. There is a growing threat that we humans could be on our way to enter a dark tunnel where 
an initially mild infection could become a dangerous and even fatal disease in the absence of 
an effective antibiotic, just like our old days before discovering antibiotics. 
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The reason that makes antimicrobial resistance (AMR) a global public health threat is that 
antibiotic-resistant bacteria are widely spreadable and not limited to specific regions or 
countries. The open world that we live in nowadays, where it is easy to travel around the world 
(except for this year 2020), makes all the edges of the world brought together, from developing 
to developed countries. A perfect and very live example of the world being interconnected is 
the super rapid spread of SARS-COV-2 which causes COVID-19 around the world, where 
there is no longer a single country without positive cases of such disease.  
There is a growing attention from the scientific world of studying the role of tourism and 
international travel in the dissemination of AMR worldwide. It has been shown that several 
factors can lead to the development of a drug-resistant bacteria in a certain region such as low-
quality healthcare, lack of clean water source, insufficient sanitation, and most significantly the 
excess and inappropriate use of antibiotics (Frost, Van Boeckel, Pires, Craig, & Laxminarayan, 
2019). These factors are some of the classic characteristics of most low- and middle-income 
countries. But with global traveling being easier and more affordable, it would not be 
challenging for such bacteria to spread across borders. According to the 2018 report from 
World Tourism Organization (UNWTO), there were more than 1.3 billion tourist arrivals in 
2017 (Figure 1), and much higher projections of this number are expected in the future (World 
Tourism Organization, 2018), unless the SARS-CoV-2 pandemic has a lasting impact. 
The consequences of AMR could range from an economic burden to the complete treatment 
failure of an entire class of infectious diseases. A study published in 2016 found that the 
treatment of a single case of carbapenem-resistant Enterobacteriaceae infection in the United 
States could cost more than USD $60,000, and that is a very high load on the healthcare system 
compared with a non-resistant bacterial infection (Bartsch, et al., 2017).  
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One of the most infamous examples of AMR is the multidrug-resistant Staphylococcus 
Aureus (MRSA) which is a common cause of severe infections in health facilities and 
communities. People with MRSA are more likely to die than people with a non-resistant form 
of the infection. Furthermore, according to the World Health Organization (WHO), the failure 
of third-generation cephalosporin antibiotics in treating gonorrhea has been confirmed in at 
least 10 countries (WHO, 2020). Most of these countries are developed countries, where they 
have very good antimicrobial stewardship and with low level of antibiotic-misuse. Therefore, 
AMR is already a universal problem and should be of a global concern, with close surveillance 
across all countries in order to limit the excess and unnecessary use of antibiotics.  
As mentioned before, several factors can lead to the emergence of bacterial resistance 
against a certain antibiotic. However, the inappropriate use of antibiotics is considered to be 
the leading reason, where inappropriate use could mean excessive, insufficient, or unnecessary 
use. Its importance comes from its huge impact on the evolution and spread of AMR 
worldwide, and also because it is inexpensive and not so hard to take actions that could limit 
that issue. This thesis is investigating the problem of excess and unnecessary use of antibiotics 
in Egypt to determine the size of the problem, its main causes, and possible interventions that 
could help in promoting a better antibiotic-use practices.  
Figure 1: International tourist 
arrivals (million) 
Figure 2: Health expenditure by type of 
health service provider in Egypt 
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Egypt is the most populous country in the Middle East, and is by many considered to be the 
region’s capital (Sheth, 2017). It is also the largest producer of health personnel in the area so 
that a great percentage of the non-national work force within health sector, especially 
pharmacists, in the Gulf countries are Egyptians. A study published in 2018 that investigated 
the status of licensed pharmacists in Saudi Arabia found that more than 80% of pharmacists 
are non-Saudis, and 57% of them are Egyptians (AlRuthia, Alsenaidy, Alrabiah, AlMuhaisen, 
& Alshehri, 2018). Moreover, a systematic review published in 2008 studying pharmacy 
education and practice in 13 Middle Eastern countries, showed that more than 14,000 students 
get admission into pharmacy schools every year, and over 75% of them are in Egypt (Kheir, et 
al., 2008). These facts give the country a strategic importance in regard to suggesting 
interventions to decrease antibiotics overconsumption and raise the awareness of health 
professionals about the serious effects of the development and spread of AMR. Another way 
to look at it is that the situation in Egypt regarding antibiotic dispensing resembles the situation 
in many low-and middle-income countries, so the results and recommendations could be 
generalized on a large scale of countries, hence we can plan actions to limit such a problem. 
A basic and brief overview of the structure of  the healthcare system in Egypt follows; a 
more detailed explanation is published in the Egypt Service Provision Assessment (ESPA) 
Survey of 2004 (Ministry of Health and Population, 2005). Egypt spends only 4.75% of GDP 
on health which is a very low percentage when compared with other low- and middle-income 
countries (Gericke, Britain, Elmahdawy, & Elsisi, 2018). Briefly describing the assembly of 
healthcare system and healthcare providers in Egypt, the Ministry of Health (MOH) is 
responsible for managing the public sector and monitoring the private sector. Health service 
providers in Egypt could be public hospitals, private hospitals, private clinics, pharmacies, and 
other minor organizations. When someone feels sick, the first-choice destination would be the 
pharmacy due to the easy access and the low costs of a medical advice or even treatment 
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recommendations. If there is a need for reference, the pharmacist would recommend visiting a 
doctor to get a more comprehensive evaluation of the case. In that instance, the majority would 
choose to visit a private health facility whether a hospital or a clinic, and that is because of the 
low service quality and high out-of-pocket payments within the public sector. Figure 2 shows 
that more than half of health expenditure is received by pharmacies and private clinics and 
hospitals.  
Pharmacies in Egypt represents the low-threshold point of access to health services due to 
their availability almost all day long, even on weekends, and also because customers do not 
have to pay extra fees to get medical advice. Most first contact for mild illnesses and minor 
infections - for which antibiotics are often inappropriately given - is with the local pharmacy. 
We have data to show that pharmacies tend to give out antibiotics indiscriminately. Hence, 
these are a very appropriate first target in trying to make a change in antibiotic usage patterns. 
A pharmacist or a pharmacy technician/assistant can dispense almost any medication without 
the need of a prescription. However, they refrain from recommending medicines for chronic 
diseases without a professional medical advice from a doctor. This thesis focuses on the over-
the-counter dispensing of antibiotics as it might cause antibiotic misuse, which is a leading 
reason for the development of AMR. Several studies investigated the dispensing patterns of 
antibiotics in Egypt, and one of them was a simulated patient study in Upper Egypt. The study 
found that almost all pharmacies (99%) included in the study dispensed amoxicillin for a 
simulated patient with a common cold or viral infection, and the majority did it even without 
collecting enough information that could support that recommendation (Abdelaziz, et al., 
2019). 
This unattended and irresponsible dispensing of antibiotics from community pharmacies can 
be explained by the lack of knowledge of the pharmacy worker about the unwanted magnitudes 
of such practice. A large proportion of the pharmacy staff in Egypt are not trained pharmacists 
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or even have any pharmaceutical study background; as we see in the previously cited study 
(Abdelaziz, et al., 2019), in nearly half (44%) of the cases, a non-pharmacist provided the 
service.  
Knowing that antibiotics usually lie in the middle- or high-priced medicines category, 
seeking financial profit could be a motive that drives a pharmacist to recommend an antibiotic 
as a treatment choice. First and foremost, a pharmacy is a business that pursues profit, and with 
the lack of strict rules and regulations that control antibiotics’ dispensing, making profit could 
rule over professionalism. In a study investigating the pharmacists’ motives for selling non-
prescription antibiotics, that was the statement of a community pharmacist “So, the owner is 
thinking for the business and getting more money and the pharmacist is under pressure to sell 
and to get more profit” (Black, Cartwright, Bakharaiba, Al-Mekaty, & Alsahan, 2014). 
The WHO commissioned a multi-country public awareness survey to investigate public 
awareness about antibiotic use, carried out in 2015 among the public of 12 countries, among 
them Egypt. The survey reported that 32% of all respondents thought that they should stop 
taking antibiotics when they felt better, and particularly respondents in Egypt and Sudan were 
likely to think so. Furthermore, 34% of the respondents from Egypt agreed that it is okay to 
take antibiotics from a friend or a family member so long it was apparently used for the same 
illness (WHO, 2015). This indicates that there are several ways for people to get antibiotics 
with, other than a hospital or a pharmacy, and with the absence of a well-established 
prescription registry, it is almost impossible to track down the actual use of antibiotics in Egypt 
in order to monitor and control the consumption of such valuable substances. 
The Egyptian law of Pharmacy has classified pharmaceutical products into categories 
according to their toxicity and conditions of purchasing, preservation and dispensing in the 
pharmacy. The law states that all antibiotics are in Category-2 with other products like 
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anaesthetics and opioids where dispensing or re-dispensing of such products should only 
happen according to a prescription from a specialised physician (Ministry of Health, 1971). So, 
it turns out that there are in fact regulations that prevent selling antibiotics without a 
prescription, but no one is following them, and no one is monitoring or inspecting the 
dispensing activities. Pharmacist Asem Seada, who works as a pharmaceutical inspector in the 
Egyptian pharmacy administration, was asked if they check the regime of antibiotic dispensing 
during a pharmacy inspection and he answered “For now, we do not have any assignments to 
check antibiotic dispensing in our inspection procedures” (Seada, 2019). Moreover, despite the 
availability of the practice guidelines and the complete awareness of physicians over these 
guidelines, a large share of them tend to prescribe antibiotics even if it is not necessary for the 
case due to the financial and scientific incentives and other privileges they might get from the 
pharmaceutical companies selling these antibiotics. However, that is another issue, which is 
not covered in this thesis. 
All of this reinforces the presumption that the inappropriate and unnecessary use of 
antibiotics in Egypt is a potential problem that calls for urgent and effective interventions. 
Therefore, the main goal of this thesis is investigating the size of the problem of self-medication 
and over-the-counter dispensing of antibiotics in Egypt, as well as suggesting some policy 
prototypes that could fit in the Egyptian context and other countries that have similar conditions 
as Egypt that may help in controlling and limiting the problem. The thesis is a systematic 
literature review of the published literature studying the prevalence of antibiotic dispensing 
without prescription and self-medication with antibiotics. A similar systematic review 
published in 2017 reviewed the situation of self-medication with antibiotics in the Middle East, 
but it did not include any studies from Egypt (Alhomoud, et al., 2017). Therefore, it appeared 
to be useful to conduct such a review about the situation in Egypt in order to point out the 
problem and suggest possible interventions to limit its consequences. 
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1.1 Objectives 
1.1.1 Primary Objective 
The main aim of this thesis is investigating the problem of self-medication and over-the-
counter dispensing of antibiotics in Egypt to determine the size of the problem and its main 
causes. 
1.1.2 Secondary Objective 
Designing prototypes of policies that are applicable in the Egyptian context to limit the 
unwarranted overuse of antibiotics. 
1.1.3 Research Question 
What is the prevalence of self-medication and over-the-counter dispensing of antibiotics in 
Egypt? 
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2.0. Methodology 
2.1. PICO (Population, Intervention/Exposure, Comparison & Outcome) 
The population studied in this review is the Egyptian population generally, with primary 
focus on Egyptian antibiotic consumers and pharmacy workers. The exposure of interest here 
is the purchase of antibiotics without a prescription. The comparison would be against people 
who do not use non-prescription antibiotics or pharmacists who refrain from dispensing 
antibiotics without a prescription. The primary outcome here is actually getting an antibiotic 
without a professional medical advice, which in turn might lead to antibiotic misuse, which can 
plausibly promote the development of antimicrobial resistance as a secondary outcome. 
2.2. Definitions, search terms, and search strategy 
Self-medication and self-administration are terms that prescribe the action of taking 
medicine on one's own initiative, or on the advice of another person, without a prescription or 
consulting a doctor (Hernandez-Juyol & Job-Quesada, 2002). Over-the-counter drug 
dispensing is the action of selling drugs in pharmacies or elsewhere without a prescription from 
a registered medical practitioner (Nagaraj, Chakraborty, & Srinivas, 2015). An antibiotic or 
antibacterial is a natural or synthetic material that can kill or suppress the growth of bacteria 
with different mechanisms (Felman, 2019). 
I have conducted a systematic search of all the available published literature through 
different databases: Medline, Scopus and ProQuest using different keywords derived from the 
main keywords (self-medication, over-the-counter, antibiotic and Egypt). The search strategy 
from the systematic review of Alhomoud et al. was adopted with some reforms to comply with 
my research question (Alhomoud, et al., 2017). Some keywords were searched as Medical 
Subjected Headings (MeSH) terms and others as normal phrases. Table 1 shows the search 
strategy where terms in the same box were combined with OR and the boxes themselves were 
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combined with AND. Reference lists were also followed up to identify more eligible 
unidentified studies.  
Table 1: A list of search terms used in databases (Medline, ProQuest and Scopus). 
Search terms for 
“Antibiotics” 
AND 
Search terms for  
“Self-medication” 
AND 







“Rational use” OR 




“Arab Republic of 
Egypt” 
 
2.3. Inclusion and exclusion criteria 
The literature search included all the published literature until September 2020, and all the 
identified records were title-screened to exclude duplicated records and studies that were not 
relevant to the research question. Further screening of the studies’ abstracts led to the exclusion 
of studies; (1) conducted in countries other than Egypt, (2) addressed self-medication generally 
without exclusive results for antibiotics, (3) based on qualitative analysis, (4) investigated the 
pattern of antibiotic prescription in hospitals, (5) were systematic reviews not focusing on 
Egypt, and (6) with unavailable full text. During full-text screening an additional study was 
excluded due to the unavailability of the results’ tables and figures in the study (El Maraghy, 
Younis, & Abbas, 2016). Studies would be eligible for inclusion, if they were quantitative 
studies with full texts, investigating the pattern of self-medication with antibiotics, and/or the 
purchase of antibiotics without a physician’s prescription in Egypt. Figure 3 describes the 
whole process of literature search from records identification and screening to inclusion and 
exclusion, in the form of a PRISMA diagram (Moher, Liberati, Tetzlaff, & Altman, 2009). 
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2.4. Quality assessment of included studies 
Since all studies included in the review are cross-sectional studies, I have used a Newcastle-
Ottawa Quality Assessment Scale (NOS) modified by Modesti et al. in order to assess the 
methodological quality of the included studies (Modesti, et al., 2016). NOS is a quality 
assessment tool developed by a collaboration between the Universities of Newcastle, Australia 
and Ottawa, Canada to assess the quality of non-randomized studies included in systematic 
reviews and meta-analyses (Wells, et al., 2020). The model used here was modified to fit cross-
sectional studies where each study can gain a maximum of 10 stars on a star-based grading 
system, in which a study is judged on three different aspects: the selection of the study groups, 
the comparability of the groups, and the ascertainment of either the exposure or outcome of 
interest (Appendix 1). I also followed the PRISMA (Preferred Reporting Items for Systematic 
reviews and Meta-Analyses) guidelines during the development of the study protocol and the 
analysis plan (Moher, Liberati, Tetzlaff, & Altman, 2009). 
2.5. Data extraction and management 
I have developed a data abstraction tool and used it to extract data from the included papers 
(Appendix 2). The characteristics of each study such as the author, study population, study 
design, and others were noted and arranged in Table 2. The form of result presentation was not 
consistent in all studies due to the diversity of study subjects. While pharmacy workforce was 
the study population in some of the studies, other studies took standard citizens or students as 
their study subjects. Some of the studies presented the results in percentages, others presented 
them in numbers. Whenever it was possible, results presented in the same way were gathered 
to obtain a larger study sample and more representative estimates. It is worth mentioning that 
I attempted to obtain primary data about the overall sales of antibiotics in Egypt across public 
and private sectors, but the data was only commercially available and at a price that made it 
unfeasible for this analysis. 





















 Figure 3. PRISMA diagram of the study identification and selection process. 
Records identified through  
database searching 
Medline: 407, Scopus: 19 ProQuest: 1229 
Records identified through  
other sources 
N= 8  
Records screened for relevance  
(Titles) 
N= 1663 























➢ Duplicated = 22 















Studies included   
N= 10 
Records excluded  
N= 139 
➢ Studies conducted in countries other than 
Egypt. 
➢ Studies addressed self-medication generally, 
without exclusive results for antibiotics. 
➢ Studies discussed the prevalence of certain 
antibiotic-resistant bacteria in Egypt (not 
relevant to the research question). 
➢  Studies did not have a proper presentation of 
the results (percentages or numbers). 
Records excluded 
➢ Qualitative studies 
N= 10 
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Females 50% 
Primary education and lower 29% 
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Males 46% 
Females 54% 
Primary education and lower 14% 
Secondary education and higher 86% 








1100 18 – 85 
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Primary education and lower 6% 














Primary education and lower 18% 
Secondary education and higher 82% 
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Females 67% 
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Males 56% 
Females 44% 
BSc in Pharmacy 63% 
University level (not pharmacy) 18% 




















238 25 – 51 
Males 71% 
Females 29% 
BSc in pharmaceutical sciences 61% 
Non-pharmaceutical education 29% 
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Questionnaire 12 months 
(30%) of the respondents admitted acquiring 
antibiotics without a prescription during the 
last 12 months. 
Pharmacy 58.7% 







Questionnaire 1 month 
Self-medication with antibiotics was reported 
by 260 of 422 respondents (61.6%) during 







Questionnaire 12 months 
More than half of participants reported  
self-medication with antibiotics (53.9%). 





Questionnaire 3 months 
The total usage rate of unprescribed 








Questionnaire 12 months 
The use of antibiotics without prescription in 
the past 12 months was reported by  






El Ezz  
et al. 
Questionnaire 1 month 
Overall consumption of non-prescribed 
antibiotic was (41.5%). 
------ ------ 5 
Dooling 
et al. 
Questionnaire 2 months 
Overall, 326 (81%) pharmacists reported 
dispensing antibiotics for treating colds 











The Simulated Client visited 104 pharmacies 
and was sold an antibiotic without a 











Out of 238 visits of the Simulated Client, 
Amoxicillin was dispensed without a 
prescription in (98.3%) of the cases. 
Pharmacy 100% Amoxicillin 6 
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3.0. Results 
3.1. Characteristics of the included studies 
After the exclusion of duplicated records (n=22) and non-relevant studies based on both title 
and abstract screening (n=1621), twenty full-text studies were read to check their eligibility. 
Furthermore, 10 more studies were excluded as they did not meet the inclusion criteria and 
finally, the remaining 10 studies were included in the review (Figure 3). All the included studies 
are cross-sectional studies where authors either used Simulated Client approach, questionnaires 
and/or surveys to collect data on self-medication with antibiotics and its dispensing without 
prescription. Table 2 shows the detailed characteristics of the included studies. 
The included studies were conducted in three major cities across Egypt, namely Cairo, 
Alexandria and Minia, and were published in the years from 2009 and 2019. Study subjects 
varied between general public, students or pharmacy workforce, with various study settings 
such as pharmacies, out-patient clinics, university campuses, houses, cafes and streets. In most 
of the cases, sample sizes were justified and satisfactory with the peak at 1100 respondents and 
a minimum of 104 cases. Study subjects had a wide age variation which ranged from (2 – 85 
years), as children were represented by their parents or caregivers. Participants in all studies 
had different educational levels, except for one study (Abou El-Ezz & Ez-Elarab, 2011) where 
all study subjects were university students.  
3.2. Prevalence rate of non-prescription use/dispensing of antibiotics 
3.2.1. Self-medication with antibiotics  
Out of the 10 studies included in the review, 7 studies investigated the pattern and the rate 
of self-medication with antibiotics among general public and/or university students. The 
prevalence rate of non-prescription consumption of antibiotics recorded by the studies ranged 
from 29.8% (Elmasry, et al., 2013) to 64.3% (El-Hawy, et al., 2017). Gathering results from 
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the 7 studies yielded a sample size of 4371 participants, out of which 2001 respondents (46%) 
reported the use of antibiotics during the recall period established by each study, which ranged 
from 1 to 12 months. Table 4 describes the rate of using antibiotics without prescription from 
each study separately as well as the overall prevalence rate after combining the results together. 
3.2.2. Dispensing antibiotics without prescription 
While most of the included studies used questionnaires interviewing general public, three 
studies focused on pharmacy workforce as study subjects to inspect their pattern of dispensing 
antibiotics without prescriptions. One study used interview questionnaire also as a method of 
data collection (Dooling, et al., 2014) and the other two studies used Simulated Client approach 
(Abdelaziz, et al., 2019) (Amin, Amine, & Newegy, 2017). As it appears in table 5, the rate of 
dispensing non-prescription antimicrobials ranged from 65% to 98%. I considered the results 
from the three studies as similar and combined them to get a sample size of 825 pharmacists 
and assistants with 76% as an overall rate of non-prescription dispensing of antibiotics. 
Table 4: The total rate of self-medication 










884 404 (45.7%) 
Scicluna  
et al. 
300 90 (30%) 
Ghazawy  
et al. 
422 258 (61.6%) 
El Nimr  
et al. 
1100 593 (53.9%) 
Elmasry  
et al. 
1006 300 (29.8%) 
El Hawy  
et al. 
359 231 (64.3%) 
El Ezz  
et al. 
300 125 (41.5%) 
Total 4371 2001 (45.8%) 
Table 5: The total rate of dispensing 
antibiotics without prescription among 











483 326 (81%) 
Amin  
et al. 
104 68 (65%) 
Abdelaziz  
et al. 
238 234 (98.3%) 
Total 825 628 (76.1%) 
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3.3. Indications and motives for non-prescription use/dispensing of antibiotics 
Except for (El-Nimr, Wahdan, Wahdan, & Kotb, 2015) and (Abou El-Ezz & Ez-Elarab, 
2011), all the other included studies reported the most frequent symptoms that required 
using/dispensing a non-prescription antibiotic. Common cold, flu, fever, tonsilitis and sore 
throat came as the most reported symptoms, and all of them are respiratory tract symptoms. 
Urinary tract infections (UTIs) was reported by (Sabry, Farid, & Dawoud, 2014) as the leading 
cause to urge dispensing or recommending an antibiotic by a pharmacy staff. Acute bronchitis, 
common cold and fever were used as case scenarios in pharmacy visits by the simulated-client 
studies (Amin, Amine, & Newegy, 2017) (Abdelaziz, et al., 2019). 
Seven of the included studies focused on general public as study subjects and their pattern 
of self-medication with antibiotics. Almost all these studies mentioned the most recurrent 
reasons and motives of self-medication. Both physician’s consultation being time consuming 
and financial issues were reported as the leading causes for self-medication, followed by having 
a previous experience with the same symptoms being “cured” by antibiotics (by their own 
subjective assessment). While (Elmasry, et al., 2013) and (Ghazawy, Hassan, Mohamed, & 
Emam, 2017) reported that perceiving common illnesses as minor and not worthy of 
physician’s consultation was a common motive for self-medication, (Scicluna, et al., 2009) 
stated that a large proportion of participants believed that they did not need a prescription to 
purchase an antibiotic from the pharmacy. 
On the other side, only one study discussed the motives that drive pharmacy staff to dispense 
antibiotics without prescriptions (Dooling, et al., 2014). Client demand and seeking financial 
profit came in the front of possible motives, followed by the pursuit of gaining client’s loyalty. 
While some pharmacists argued that they are capable of properly evaluating whether an 
antibiotic treatment was necessary or not, most of them thought that antibiotics are available 
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and easily accessible without a prescription, and if they refrained from dispensing an antibiotic 
upon a customer’s request, he will definitely get it from another pharmacy. 
3.4. Source of antibiotic, information and recommendations, and the antibiotic classes 
most frequently used/dispensed without a prescription. 
The commonest source of self-medication antibiotics as well as the recommendations and 
information regarding self-medication was the pharmacy, namely pharmacists and assistants. 
(El-Nimr, Wahdan, Wahdan, & Kotb, 2015) stated that pharmacies were common sources of 
non-prescribed antibiotics because of the fact that pharmacists do not request a prescription to 
dispense an antibiotic or charge for their medical advice. Leftovers and old prescriptions were 
the second most common source of self-medicated antibiotics followed by friends and family 
as the least common source. 
The most frequently used antibiotic class was β-lactam antibiotics in all the papers. While 
Amoxicillin name was mentioned by (Scicluna, et al., 2009) and (Abdelaziz, et al., 2019), 
(Elmasry, et al., 2013) ranked them by class as Penicillins being the most common followed 
by cephalosporins, macrolides and least used were quinolones. The combination of 
Amoxicillin/Clavulanic acid was reported by (El-Hawy, et al., 2017) as the popular choice for 
self-medication.  
3.5. Factors associated with non-prescription use/dispensing of antibiotics 
Half of the included studies tried to investigate the correlation between self-medication and 
a number of factors. Elmasry reported a significant correlation between self-medication and 
age, socio-economic level, and occupation, along with Ghazawy who found that number of 
family members had also a strong relation with self-medication (Elmasry, et al., 2013) 
(Ghazawy, Hassan, Mohamed, & Emam, 2017). Moreover, El Nimr declared a significant 
association between self-treatment and almost all the factors, while gender was the only 
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considerably correlated factor in El Hawy’s study (El-Nimr, Wahdan, Wahdan, & Kotb, 2015) 
(El-Hawy, et al., 2017). On the other hand, only one study tested the association between non-
prescription antibiotic dispensing and the characteristics of the pharmacy staff, and they found 
that having less than a university education was the only factor strongly correlated with 
inappropriately recommending antibiotics for colds by a pharmacy staff (Dooling, et al., 2014). 
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4.0. Discussion 
Antimicrobial resistance is a serious public health threat that affects the whole world 
medically and economically. The inappropriate and unnecessary use of antibiotics that results 
from either self-medication, non-prescription dispensing or over prescription, is  documented 
as an important contributing factor in exacerbating the spread of AMR (Michael, Dominey-
Howes, & Labbate, 2014). It is true that antimicrobial self-medication and non-prescription 
dispensing of antibiotics are issues not just limited to low- and middle-income countries, since 
a high prevalence was reported by a study from Spain, where more than half of the visited 
pharmacies dispensed antibiotics without a prescription (Guinovart, Figueras, & Llor, 2018). 
However, the magnitudes of AMR would negatively affect low- and middle-income countries 
the hardest, due to the weak infrastructure of health systems and the generally low healthcare 
standards in these countries. 
According to a comprehensive study by Klein and colleagues, Egypt was ranked third 
among the highest low- and lower-middle-income countries regarding antibiotic consumption 
during the year 2015 (Klein, et al., 2018). Several systematic reviews have been conducted to 
address the issue of excessive and unnecessary use of antibiotics in developing countries, and 
countries of the Middle East, without reporting the situation in Egypt (Alhomoud, et al., 2017) 
(Sakeena, Bennett, & McLachlan, 2018). Therefore, this review aimed to gather the results 
available from the published literature to provide solid evidence on the improper use of 
antibiotics in Egypt and highlight the strategic importance of applying corrective interventions 
in Egypt in tackling the spread of AMR.  
The initial idea of the thesis was getting primary data of antibiotic sales in Egypt during the 
period from 2000 to 2020 and comparing them with the numbers of Norway after adjusting for 
several confounding factors. I requested the data from IQVIA, which is an international 
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company that possesses reliable statistical sales data of medications across the world and sells 
this data for marketing and scientific purposes (IQVIA, 2020). However, it turned out that 
obtaining this primary data was far too expensive for the purposes of a master thesis. Thus, I 
modified the thesis methodology to be a systematic review depending on the data collected by 
published literature. 
4.1. Statement of the principal findings and its consistency 
This review aimed at summarizing the situation in Egypt regarding the pattern of non-
prescription use and dispensing of antibiotics. The overall prevalence rate of self-medication 
with antimicrobials among general public was relatively high (46%), as well as the rate of 
dispensing antibiotics without prescription (76%), which are quite alarming. Also, the review 
tried to identify some of the reasons and factors related to this high prevalence. Financial issues, 
time consuming doctor visits and the ease of accessing antibiotics were the most commonly 
cited reasons for self-medication. Occupation was a leading factor that had a significant effect 
in most of the studies, and that is understandable since it is a fundamental aspect of socio-
economic status. As per pharmacy staff, pursuing financial profit and the absence of strict 
regulations were the driving motives for dispensing non-prescription antibiotics, while the 
staff’s level of education was the factor with the strongest effect. Identifying these factors and 
reasons is very important when it comes to designing policies and interventions to tackle such 
a problem. 
Antimicrobial use, whether it is prescription or non-prescription, exerts antimicrobial 
selection pressure, which is a core mechanism in developing bacterial resistance against 
antibiotics (Spellberg, et al., 2008). However, non-prescription dispensing of antibiotics is 
usually accompanied with the lack of proper counselling and complete instructions on how to 
use medications, as mentioned by most of the studies included in the review. Hence, a high 
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tendency was reported among the public to stop taking medications once the symptoms 
disappeared and keep antibiotic leftovers to use it further if they became sick again. Moreover, 
Scicluna et al. found a significant association between the act of hoarding antibiotics and self-
medication, and therefore, leftovers were an important source of acquiring non-prescription 
antibacterial agents (Scicluna, et al., 2009). Furthermore, it is so common in Egyptian 
pharmacies to dispense sub-therapeutic doses of antibiotics either upon client request or as a 
part of a cold treatment course called as “Cold Group”, and this gives the same result as 
discontinuing medications upon symptomatic improvement (Amin, Amine, & Newegy, 2017). 
All these factors make non-prescription more problematic than prescription use of antibiotics. 
Numerous similar systematic reviews were published exploring the rate of self-medication 
with antibiotics and their non-prescription dispensing on either global, regional or country 
levels. The rate of self-medication in this current review was similar to that of a global review, 
where the rate of using non-prescription antibiotics within African population was 48% 
(Morgan, Okeke, Laxminarayan, Perencevich, & Weisenberg, 2011). An even higher global 
rate (59%) was calculated by another worldwide review, with studies conducted in developing 
countries reporting the highest prevalence (Limaye, Limaye, Krause, & Fortwengel, 2017). 
The most commonly used antibiotic class in both these reviews was Penicillins, while 
amoxicillin was mentioned by name as the most popular antibiotic in another systematic review 
(Aceijas & Henry Selvaraj, 2019), which are all in line with the results of this review. Just like 
it is in this review, the most recurrent source of antibiotic and information in all the three other 
systematic reviews was the pharmacy (Aceijas & Henry Selvaraj, 2019) (Morgan, Okeke, 
Laxminarayan, Perencevich, & Weisenberg, 2011) (Limaye, Limaye, Krause, & Fortwengel, 
2017). Furthermore, two other worldwide systematic reviews were published investigating the 
practice of dispensing antibiotics without prescription. The pooled rate in this review was 76%, 
whereas Auta et. al. found that the overall proportion of non-prescription supply of antibiotics 
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was 62% (Auta, et al., 2019). However, the prevalence rate in the other review was extremely 
variable, as it ranged from 8% to 100% without calculating a pooled estimation (Sakeena, 
Bennett, & McLachlan, 2018).  
4.2. Consequences and magnitudes of the excessive unnecessary use of antibiotics 
4.2.1. Multi-drug resistant bacterial infections 
The improper and careless use of such exceptionally valuable substances as antimicrobial 
agents would definitely result in worldwide negative effects on the scale of public health and 
economic development. The inappropriate use of antibiotics in Egypt is not limited to non-
prescription use, as physicians’ prescribing practice is not optimal in either private or public 
sectors. A point prevalence survey of antibiotics use conducted in 18 public Egyptian hospitals 
reported a very high rate, as 59% of the patients admitted to these hospitals received at least 
one antibiotic (Hassan, Ibrahim, & Guinaidy, 2011). Another study was performed in 
Orthopedic Department, Tanta University hospital stated a remarkably high rate of antibiotic 
prescription (98%) and a very low appropriateness level (11%) (Talaat, et al., 2014). Moreover, 
Aboelhassan and colleagues found that 46% of the patients admitted to Cairo University 
Hospital were improperly prescribed antibiotics for treating acute viral respiratory tract 
infections, which are not susceptible to antibacterial agents (Aboelhassan, Rezk, Saber, & Al-
Harrass, 2019). 
This excessive and unwarranted use of antibiotics could lead to dire consequences for the 
public health status of Egyptians; this has already begun to manifest in the form of the spread 
of multi-drug resistant (MDR) bacteria in the Egyptian community. In a semi-international 
study reporting the incidence of β-lactam resistant Enterobacteriaceae in 17 different countries, 
the rate was very high in Egypt (38.5%) compared to countries with better profile of antibiotic 
stewardship, like The Netherlands (2%) and Germany (2.6%) (Bouchillon, et al., 2004). 
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Numerous studies have estimated the prevalence of MDR bacteria in Egypt and found that 
proportions were either high or very high. In a study performed in 3 large university hospitals 
in Egypt on bloodstream infections, they found that 60% of the isolated Staphylococcus Aureus 
cultures were methicillin resistant, whereas 79% and 39% of Klebsiella Pneumonia and 
Escherichia Coli isolated cultures respectively exerted β-lactamase enzymes (Saied, et al., 
2011). Another study, focused on meningitis-causing bacteria through testing antibiotic 
susceptibility on cultures isolated from cerebrospinal fluids (CSF), revealed that 37% of the 
isolates were MDR and 100% of them were resistant against Penicillin and Ampicillin 
(Abdelkader, Aboshanab, El-Ashry, & Aboulwafa, 2017). Unlike the previous two studies, 
Khalifa and colleagues gathered bacterial cultures from diverse body tissues like blood, urine, 
respiratory sputum, and skin, and they reported that the proportion of MDR bacterial 
phenotypes were as high as 93%, where 75% of the bacterial cultures released β-lactamase 
enzymes and 59% of them were resistant against quinolones (Khalifa, et al., 2019). 
As mentioned before, AMR could create a huge financial load on health systems due to the 
complexity of treating multi-drug resisting bacterial infections. This financial burden would be 
worse in low- and middle-income countries given the magnitude of the problem and the limited 
healthcare budgets of these countries. In Egypt, the public healthcare system is poorly 
constructed with a very low proportion of the GDP spent on health (4.75%) (Gericke, Britain, 
Elmahdawy, & Elsisi, 2018). With the increasing spread of bacterial infections resistant to 
conventional antibiotics, it would be necessary to use new and expensive treatment choices. 
These extra costs could be beyond the limited means of the healthcare system as well as the 
patients themselves, leading to the system’s collapse with higher rates of mortality from 
communicable diseases. 
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4.2.2. Imbalance in the supply and demand curves of antimicrobial agents 
The excessive and unnecessary use of antibiotics poses a heavy weight on the demand side 
of the scale causing an imbalance between demand and supply, along with the critical decline 
of investment in researching new antibiotics. The number of new antibacterials approved for 
use in the USA has fallen over time, which is a potential indicator on the drop of research 
activities developing new agents (Figure 4) (Ventola, 2015). The lack of interest in this research 
field is understandable and can be attributed to multiple factors. Firstly, the improper use of 
antimicrobial agents leading to the accelerating spread of bacterial resistance makes the 
pharmaceutical companies reluctant to spend huge funds for developing a new drug that could 
lose its efficacy in short time. According a report by the Centers for Disease Control and 
Prevention (CDC), several bacterial strains has developed resistance against newly approved 
antibiotics in a very brief period after their approval such as Daptomycin and Ceftazidime-
Avibactam (Figure 5) (CDC, 2019). This actually corresponds with the reality that Egyptian 
pharmacists would tend to promote and dispense newer antibiotics preferentially as a mark of 
cleverness to gain the loyalty of new customers as stated by the pharmacists themselves 
(Dooling, et al., 2014). In addition, high profit margins at the point of sale for these costly new 
drugs are a further incentive for pharmacists to dispense them. 
Secondly, antibiotics are primarily intended to be short term curative drugs, where the 
treatment course is short and less expensive when compared with drugs treating chronic and 
complicated diseases. Along the same lines, when a pharmaceutical company invests in a new 
drug and brings it to market, they put a high price on it to compensate its development costs 
that could reach nearly 1 billion USD (Wouters, McKee, & Luyten, 2020). This would limit 
the new product’s market to high-income countries that are capable of buying and applying it 
in their treatment regimens, while low- and middle-income countries, where infectious diseases 
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are most common, would not be able to afford it. These factors and more make researching 
new antibiotics less appealing to investors and pharmaceutical companies. 
4.3. Interventions applied globally to limit the unwarranted use of antibiotics 
Interventions intended to halt the inappropriate use, dispensing and prescribing of antibiotics 
should originate from the factors and reasons causing such behavior. For instance, to overcome 
physicians’ over-prescription of antimicrobials, we need educational and legislative measures 
addressed to this category of community, and so on. A group of effective government policies 
and interventions applied in various regions around the world to reduce human antimicrobial 
use were reviewed in a comprehensive systematic review published in 2019 (Rogers Van 
Katwyk, et al., Government policy interventions to reduce human antimicrobial use: A 
systematic review and evidence map, 2019). The interventions listed in the review were 
directed to health care workers, pharmacists and general public, and they ranged from 
educational and awareness campaigns to the making of new laws and regulations or the 
enforcement of already existing ones. Solutions could also come from decreasing the need and 
Figure 4: Number of new antibiotics 
approved in USA versus year intervals  
Source: (Ventola, 2015) 
Figure 5: The development of antibiotic 
resistance: A timeline of key events. 
Source: (Ventola, 2015) 
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demand for antibiotics at the first place. This could be achieved by improving the level of 
sanitation and the access to a clean water supply, especially in the poor districts of low- and 
middle-income countries. Promoting vaccination against MDR bacteria is also a good approach 
to lessen the complexity of treating infectious diseases. Another promising intervention could 
be establishing publicly funded laboratories with high capacities to identify infectious agents 
through bacterial cultures and determine the antibiotic of choice for each infection and avoid 
wasting valuable last resource antibiotics on simple cases. Facilitating the access to proper and 
reasonable health services is very important too, and therefore, strengthening the infrastructure 
of healthcare systems is decisive in combating the viciously growing antimicrobial resistance. 
4.4. Possible effective interventions that could fit in the Egyptian context 
4.4.1. Public awareness campaigns 
The highly digitalized world we live in, makes it appear easy and inexpensive to deliver any 
sort of message to a wide range of audiences through different communication channels such 
as TV, radio and all kinds of social media platforms. This represents a golden opportunity to 
educate the public about the dire consequences of AMR and engage them more as vital 
contributors in promoting healthy use of antibiotics, through producing creative shows, TV-
spots and commercials. Since the 1990s, television and radio have played a critical role in 
discussing and improving the social and health behaviors of Egyptians with series and podcasts 
specifically developed to address such issues (Elkamel, The use of television series in health 
education, 1995). While family planning and anti-female genital mutilation (FGM) TV-
promotions were the most famous campaigns with many catchy phrases, TV-spots and 
commercials have targeted other health issues such as vaccination, breastfeeding, hepatitis C 
(HCV) and nutrition (Elkamel, 2020). These campaigns appeared to have a notable effect in 
modifying social and health behaviors, as described by Farag Elkamel in his paper “Knowledge 
and Social Change” (Elkamel, 2019). 
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Social media platforms are also a great arena for sharing educational awareness messages 
by using the advertising tools connected to these websites, which is usually cheaper and often 
more targeted than using television advertisements. A comprehensive report on the internet-
penetration in Egypt found that 41% of the population are active social media users, with 
Facebook, YouTube, WhatsApp, FB Messenger and Instagram as the top 5 most commonly 
used platforms in Egypt (Kemp, 2020). The same report stated that more than 75% of the 
advertising audience are from 18 to 44 years old. This age range is an important target for such 
campaigns to raise their awareness of proper antibiotic use and the possible harmful effects of 
AMR, as they are either independent university students, educated working youths, or fathers 
and mothers. 
4.4.2. Educational and training-based interventions directed to healthcare personnel  
Health care workers, either physicians or pharmacists, are the corner stone in the cycle of 
antibiotic use by prescribing or dispensing. Therefore, they are crucial targets in the action-
plan for limiting the inappropriate medicine-use. The educational curriculum of medical and 
pharmacy schools should give AMR a higher attention and stress on the importance of adhering 
to the international guidelines for treating infectious diseases. Even for practicing physicians 
and pharmacists, it has been proven that educational interventions always have positive effect 
in decreasing the rate of antibiotic prescription and dispensing as well as the appropriateness 
of the prescribed antibiotic class (Roque, et al., 2014).  
Numerous studies were conducted to explore the effect of educational approaches in raising 
the level of adherence to guidelines and shrinking the frequency of antibiotic prescription. Two 
studies have found a significant change in the antibiotic-prescription practice between before 
and after applying educational courses to the physicians treating upper respiratory tract 
infections (URTIs), with 8% reduction in the rate of antibiotic prescription (Ahmed & Soltan, 
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2018) and an adherence rate improved from 54.7% to 78.2%, and these improvements were 
statistically significant (Amer, Bedwani, Shehata, & Abouelfetouh, 2018). Another study 
focused on the use of antimicrobials for surgical prophylaxis in five Egyptian surgical hospitals 
and found that all the parameters of prescribing practice have significantly improved after 
holding a two-day training program for the physicians involved in surgical procedures in these 
hospitals (Saied, et al., 2015). However, Kandeel and his group chose to direct their educational 
campaign to a wider range of audience including the physicians, pharmacists and general public 
in Minya district, Egypt, and reported positive outcomes of their campaign at all levels of study 
subjects (Kandeel, et al., 2019). All that indicates the crucial corrective role that educational 
interventions could play in improving antibiotic use patterns in Egypt. 
4.4.3. Designing new policies and regulations along with enforcing the existing ones 
As a pharmacist, I was privileged to practice pharmacy in Egypt, Saudi Arabia and Norway 
and experience the very distinct patterns of dealing with antibiotics in three countries that have 
widely different levels of personal income. In Egypt, despite the existence of laws and 
regulations that designate antibiotics as a prescription-only drugs, pharmacy workforce kept 
dispensing antibiotics without prescriptions and ignoring these regulations, and that is due to 
the lack of control from governmental bodies (Ministry of Health, 1971). This situation was 
the same in Saudi Arabia until May 2018 when the Saudi government decided to put the law 
in action and revealed that lawbreakers will be subjected to legal penalties such as withdrawal 
of pharmacy practicing license, a massive fine that could reach to $ 25,000  or even spending 
6 months in prison in case of violations (Saudi Ministry of Health, 2018). Nevertheless, the 
situation is very different in Norway with quite low level of antibiotic consumption, as they 
have always been prescription-only medicines, along with a strong commitment to the 
guidelines in both primary care and hospitals and the presence of a surveillance system for 
outpatient antibiotic use (Gravningen, Field, Blix, Asfeldt, & Småbrekke, 2020). 
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The effect of the law enforcement in Saudi Arabia was phenomenal as the non-prescription 
antibiotic sales declined sharply. In fact, I have experienced that influence myself, but it was 
also scientifically proved by a before-and-after study that used the Simulated Client approach 
and found that dispensing antibiotics without prescription dropped from 96% and 87% to 12% 
and 5% for pharyngitis and urinary tract infection simulated client scenarios, respectively 
(Alrasheedy, et al., 2020). Applying legal interventions has been evidenced effective in many 
countries around the world, especially low- and middle-income countries like in Latin America 
as reported in several studies from this area (Rogers Van Katwyk, et al., 2019). In Egypt, the 
regulations and inspection teams are already there, but what is needed is to put these rules in 
action and assign those inspectors with tasks related to antibiotic dispensing control. 
Another promising policy prototype that could be directed to improper prescription 
practices, is excluding antibiotics from the marketing activities of pharmaceutical companies 
by designing regulations that force physicians to prescribe antibiotics by their generic names. 
Despite the availability of the guidelines and the full awareness of physicians with it, a large 
proportion of them incline to prescribe antibiotics unnecessarily, tempted by the scientific and 
financial privileges they might get from the pharmaceutical companies when they prescribe 
their medicines frequently. I could not find a paper to support this claim, but it is well-known 
in the Egyptian drug-marketing community that pharmaceutical companies tend to make deals 
with physicians in order to increase the sales of their products on prescriptions. The application 
of this policy would neglect any bias factors that could affect the physician’s recommendation 
other than the case itself.  
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4.4.4. Strengthening the healthcare system’s infrastructure 
While all the previous interventions would not need so much funding and should be 
relatively simple to carry out, the upcoming ones could be more complicated and would 
certainly need a higher proportion of GDP to be assigned for health sector. 
One of the important factors that drive people towards the community pharmacy when they 
are sick is the weakness of the public healthcare system and its inferior service quality. Since 
32.5% of Egyptians live under the poverty line (CAPMAS, 2019, p. 77), it would be 
unaffordable for most of them to access a proper health service when needed. In Egypt, only 
students and regular employees have health insurance (Gericke C. B., 2018). Expanding the 
coverage of health insurance would secure the access to appropriate health services and 
decrease the financial burden of healthcare on poor families. Therefore, improving the public 
health sector to have better service quality and less out-of-pocket payments would be crucial 
for enhancing the public health of Egyptians and reduce the unwarranted use of antibiotics. The 
health care system reform should also involve the establishment of laboratories with high 
capacities to perform bacterial cultures and determine the antibiotic of choice for each infection 
case. 
Despite the accelerated penetration of technology in nearly all life activities around the 
world, a very minor share of pharmacies in Egypt use computers and internet in their work, 
while the rest are operating 100% manually. That makes it almost impossible to monitor and 
accurately track the change in antibiotic dispensing patterns, and as a well-known proverb says, 
“If you cannot measure it, you cannot improve it”. Therefore, it is important to push for the 
digitalization of pharmaceutical services in Egypt, which can be achieved on several steps as a 
long-term action-plan. This action-plan could start with introducing a new prerequisite about 
having a computer and internet connection as one of the requirements for opening a new 
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pharmacy and allow a specific deadline for the already existing pharmacies to apply this term. 
Having a well-established network between pharmacies and other health care providers would 
pave the way for establishing a national prescription registry, that would facilitate keeping 
prescribing and dispensing activities under surveillance, just the way it is in developed 
countries like Norway (Gravningen, Field, Blix, Asfeldt, & Småbrekke, 2020). 
4.5. Strengths and limitations of the review 
To the best of my knowledge, this is the first systematic review to assess the prevalence, 
possible causes, and clinical outcomes of antibiotic self-medication and non-prescription 
dispensing as well as to identify recommendations to reduce the irrational use of antibiotics in 
Egypt. The manual follow-up of and texts within articles allowed the inclusion of additional 
relevant articles that did not appear in search results. The strategic importance of Egypt as a 
target for applying corrective interventions has made the review meaningful and necessary. 
Despite the thorough search that has been done on various databases, this review is still 
affected by a degree of publication bias. The absence of a national prescription registry or any 
other authentic record for dispensing activities, makes it challenging and demanding to conduct 
studies exploring antibiotic-use patterns in Egypt. Therefore, the scarcity in the published 
literature studying the situation of self-administration and non-prescription purchasing of 
antibiotics necessarily limited the number of included studies. More relevant studies could have 
given more precise and representative results. Also, only studies published in English language 
were included, which might have caused missing a number of relevant studies. Being the only 
reviewer could be another limitation which could lead to a bias in selecting relevant studies 
and applying the inclusion and exclusion criteria. All the included studies were performed in 3 
major cities in Egypt raising the possibility of population selection bias, although these three 
cities do account for about 30% of Egypt’s total population (CAPMAS, 2020). Also, the 
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methodology of the included studies was not consistent. However, as most of the studies used 
questionnaires, the impact of methodological variation on the validity of the results is likely to 
be minimal. 
Some limitations originated from the methodological nature of he included studies. Since 
the majority of the studies used self-reported measuring tools, there was a high potential for 
social desirability bias, which is the tendency of participants to choose socially acceptable 
responses rather than choosing responses that reflect their true feelings or practices. Also, 
studies based on questionnaires are usually prone to recall bias, but some of the included studies 
tried to overcome this bias by limiting the recall period to 1 – 3 months (Elmasry, et al., 2013). 
Although only three studies had a grade 8 or higher on the NOS assessment scale, just one of 
them got a grade lower than 6. 
4.6. Recommendations 
There is an urgent need for more studies exploring the pattern of antibiotic use in Egypt and 
not just in the big cities, as it was challenging to find plenty of relevant studies. Also, the lack 
of a validated method for collecting the data on antimicrobial use would suggest establishing a 
standardized, validated survey instrument that can efficiently assess antibiotic-use behaviour 
on a large scale. In my opinion, studies based on simulated client approach were more reliable 
and resistant to bias. Therefore, I would recommend conducting more studies by the same 
methodology in various regions within Egypt. 
This systematic review is meant to be utilized by decision-makers in Egypt to take actions 
against the inappropriate use of antibiotics and halt the growing threat of AMR. Since the issue 
of AMR is a global problem, it is not expected that a single country would be able to control 
its growth. Therefore, it is important that WHO and other international health organizations 
apply some pressure on the governments of countries that have high rates of non-prescription 
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antibiotic-use to put all the needed laws and regulations into action. As not every intervention 
would be effective in every country, it was essential to identify just some of the solutions that 
could make a difference in the Egyptian context and similar communities. There are a lot of 
missed chances to raise the public health of Egyptians, and it is to be hoped that decision makers 
will be able to take the necessary actions in order to seize some of these opportunities.  
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5.0. Conclusion  
According to the WHO, at least 700,000 people die of an antimicrobial resistant infection 
every year (WHO, 2019). However, by 2050, it is estimated that 10 million lives would be in 
danger, and a possible cumulative economic loss of nearly 100 trillion USD due to the growing 
spread of AMR (WHO, 2019). Being a global threat, AMR calls for urgent international efforts 
to limit the unnecessary consumption of antibiotics and launch antibiotic-stewardship programs 
around the world especially in low- and middle-income countries.  
The results of this systematic review indicate high rates of non-prescription dispensing and 
use of antibiotics. These activities are usually linked with the improper use of antibiotics, which 
can be avoided through the application of various strategies and policies that have been proven 
effective in other countries with similar conditions as Egypt. Public awareness campaigns, 
educational and training programs for physicians and pharmacists, improving the infrastructure 
of the health delivery system and the enforcement of laws and regulations are very promising 
strategies to decrease the unwarranted use of antimicrobials in Egypt. Most of these corrective 
measures are not too complicated to be applied and not financially demanding either.  
The WHO and other international health organizations should apply some pressure on the 
government to enforce the already existing laws and regulations and establish more stringent 
inspecting procedures. Despite the announcement of finalizing a national action-plan to combat 
AMR in Egypt, it was neither published nor applied (WHO, 2018). The WHO should enact its 
parental role to monitor the release of such action-plan and ensure its application. 
The most challenging phase of producing this review was finding relevant studies, due to 
the scarcity of published literature from Egypt. Therefore, more studies are needed and best to 
be conducted using the simulated client approach as it could be more representative with less 
sources of bias.  
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NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE 
 (adapted for cross sectional studies) 
Reference: (Sabry, Farid, & Dawoud, 2014)      Grade: 6 
Selection: (Maximum 5 stars) 
1) Representativeness of the sample: 
a) Truly representative of the average in the target population.  (all subjects or 
random sampling). 
b) Somewhat representative of the average in the target population.  (non-random 
sampling). 
c) Selected group of users. 
d) No description of the sampling strategy. 
2) Sample size: 
a) Justified and satisfactory.  
b) Not justified. 
3) Non-respondents: 
a) Comparability between respondents and non-respondents’ characteristics is 
established, and the response rate is satisfactory.  
b) The response rate is unsatisfactory, or the comparability between respondents and 
non-respondents is unsatisfactory. 
c) No description of the response rate or the characteristics of the responders and the 
non-responders. 
4) Ascertainment of the exposure (self-medication): 
a) Validated measurement tool.  
b) Non-validated measurement tool, but the tool is available or described.  
c) No description of the measurement tool. 
Comparability: (Maximum 2 stars) 
1) The subjects in different outcome groups are comparable, based on the study design or 
analysis. Confounding factors are controlled. 
a) The study controls for the most important factor (select one).  
b) The study control for any additional factor (Class of the dispensed antibiotic).  
Outcome: (Maximum 3 stars) 
1) Assessment of the outcome: 
a) Independent blind assessment.  
b) Record linkage.  
c) Self-report.  
d) No description. 
2) Statistical test: 
a) The statistical test used to analyze the data is clearly described and appropriate, and 
the measurement of the association is presented, including confidence intervals and 
the probability level (p value).  
b) The statistical test is not appropriate, not described or incomplete. 
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NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE 
 (adapted for cross sectional studies) 
Reference: (Scicluna, et al., 2009)       Grade: 7 
Selection: (Maximum 5 stars) 
1) Representativeness of the sample: 
a) Truly representative of the average in the target population.  (all subjects or 
random sampling). 
b) Somewhat representative of the average in the target population.  (non-random 
sampling). 
c) Selected group of users. 
d) No description of the sampling strategy. 
2) Sample size: 
a) Justified and satisfactory.  
b) Not justified. 
3) Non-respondents: 
a) Comparability between respondents and non-respondents’ characteristics is 
established, and the response rate is satisfactory.  
b) The response rate is unsatisfactory, or the comparability between respondents and 
non-respondents is unsatisfactory. 
c) No description of the response rate or the characteristics of the responders and the 
non-responders. 
4) Ascertainment of the exposure (self-medication): 
a) Validated measurement tool.  
b) Non-validated measurement tool, but the tool is available or described.  
c) No description of the measurement tool. 
Comparability: (Maximum 2 stars) 
1) The subjects in different outcome groups are comparable, based on the study design or 
analysis. Confounding factors are controlled. 
a) The study controls for the most important factor (Education level).  
b) The study control for any additional factor (Gender).  
Outcome: (Maximum 3 stars) 
1) Assessment of the outcome: 
a) Independent blind assessment.  
b) Record linkage.  
c) Self-report.  
d) No description. 
2) Statistical test: 
a) The statistical test used to analyze the data is clearly described and appropriate, and 
the measurement of the association is presented, including confidence intervals and 
the probability level (p value).  
b) The statistical test is not appropriate, not described or incomplete. 
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NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE 
 (adapted for cross sectional studies) 
Reference: (Ghazawy, Hassan, Mohamed, & Emam, 2017)    Grade: 7 
Selection: (Maximum 5 stars) 
1) Representativeness of the sample: 
a) Truly representative of the average in the target population.  (all subjects or 
random sampling). 
b) Somewhat representative of the average in the target population.  (non-random 
sampling). 
c) Selected group of users. 
d) No description of the sampling strategy. 
2) Sample size: 
a) Justified and satisfactory.  
b) Not justified. 
3) Non-respondents: 
a) Comparability between respondents and non-respondents’ characteristics is 
established, and the response rate is satisfactory.  
b) The response rate is unsatisfactory, or the comparability between respondents and 
non-respondents is unsatisfactory. 
c) No description of the response rate or the characteristics of the responders and the 
non-responders. 
4) Ascertainment of the exposure (self-medication): 
a) Validated measurement tool.  
b) Non-validated measurement tool, but the tool is available or described.  
c) No description of the measurement tool. 
Comparability: (Maximum 2 stars) 
1) The subjects in different outcome groups are comparable, based on the study design or 
analysis. Confounding factors are controlled. 
a) The study controls for the most important factor (Educational level).  
b) The study control for any additional factor (Gender).  
Outcome: (Maximum 3 stars) 
1) Assessment of the outcome: 
a) Independent blind assessment.  
b) Record linkage.  
c) Self-report.  
d) No description. 
2) Statistical test: 
a) The statistical test used to analyze the data is clearly described and appropriate, and 
the measurement of the association is presented, including confidence intervals and 
the probability level (p value).  
b) The statistical test is not appropriate, not described or incomplete. 
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NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE 
 (adapted for cross sectional studies) 
Reference: (El-Nimr, Wahdan, Wahdan, & Kotb, 2015)    Grade: 8 
Selection: (Maximum 5 stars) 
1) Representativeness of the sample: 
a) Truly representative of the average in the target population.  (all subjects or 
random sampling). 
b) Somewhat representative of the average in the target population.  (non-random 
sampling). 
c) Selected group of users. 
d) No description of the sampling strategy. 
2) Sample size: 
a) Justified and satisfactory.  
b) Not justified. 
3) Non-respondents: 
a) Comparability between respondents and non-respondents’ characteristics is 
established, and the response rate is satisfactory.  
b) The response rate is unsatisfactory, or the comparability between respondents and 
non-respondents is unsatisfactory. 
c) No description of the response rate or the characteristics of the responders and the 
non-responders. 
4) Ascertainment of the exposure (self-medication): 
a) Validated measurement tool.  
b) Non-validated measurement tool, but the tool is available or described.  
c) No description of the measurement tool. 
Comparability: (Maximum 2 stars) 
1) The subjects in different outcome groups are comparable, based on the study design or 
analysis. Confounding factors are controlled. 
a) The study controls for the most important factor (Socio-demographic status).  
b) The study control for any additional factor (Gender).  
Outcome: (Maximum 3 stars) 
1) Assessment of the outcome: 
a) Independent blind assessment.  
b) Record linkage.  
c) Self-report.  
d) No description. 
2) Statistical test: 
a) The statistical test used to analyze the data is clearly described and appropriate, and 
the measurement of the association is presented, including confidence intervals and 
the probability level (p value).  
b) The statistical test is not appropriate, not described or incomplete. 
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NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE 
 (adapted for cross sectional studies) 
Reference: (Elmasry, et al., 2013)       Score: 7 
Selection: (Maximum 5 stars) 
1) Representativeness of the sample: 
a) Truly representative of the average in the target population.  (all subjects or 
random sampling). 
b) Somewhat representative of the average in the target population.  (non-random 
sampling). 
c) Selected group of users. 
d) No description of the sampling strategy. 
2) Sample size: 
a) Justified and satisfactory.  
b) Not justified. 
3) Non-respondents: 
a) Comparability between respondents and non-respondents’ characteristics is 
established, and the response rate is satisfactory.  
b) The response rate is unsatisfactory, or the comparability between respondents and 
non-respondents is unsatisfactory. 
c) No description of the response rate or the characteristics of the responders and the 
non-responders. 
4) Ascertainment of the exposure (self-medication): 
a) Validated measurement tool.  
b) Non-validated measurement tool, but the tool is available or described.  
c) No description of the measurement tool. 
Comparability: (Maximum 2 stars) 
1) The subjects in different outcome groups are comparable, based on the study design or 
analysis. Confounding factors are controlled. 
a) The study controls for the most important factor (Socio-economic status).  
b) The study control for any additional factor (.  
Outcome: (Maximum 3 stars) 
1) Assessment of the outcome: 
a) Independent blind assessment.  
b) Record linkage.  
c) Self-report.  
d) No description. 
2) Statistical test: 
a) The statistical test used to analyze the data is clearly described and appropriate, and 
the measurement of the association is presented, including confidence intervals and 
the probability level (p value).  
b) The statistical test is not appropriate, not described or incomplete. 
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NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE 
 (adapted for cross sectional studies) 
Reference: (El-Hawy, et al., 2017)       Grade: 9 
Selection: (Maximum 5 stars) 
1) Representativeness of the sample: 
a) Truly representative of the average in the target population.  (all subjects or 
random sampling). 
b) Somewhat representative of the average in the target population.  (non-random 
sampling). 
c) Selected group of users. 
d) No description of the sampling strategy. 
2) Sample size: 
a) Justified and satisfactory.  
b) Not justified. 
3) Non-respondents: 
a) Comparability between respondents and non-respondents’ characteristics is 
established, and the response rate is satisfactory.  
b) The response rate is unsatisfactory, or the comparability between respondents and 
non-respondents is unsatisfactory. 
c) No description of the response rate or the characteristics of the responders and the 
non-responders. 
4) Ascertainment of the exposure (self-medication): 
a) Validated measurement tool.  
b) Non-validated measurement tool, but the tool is available or described.  
c) No description of the measurement tool. 
Comparability: (Maximum 2 stars) 
1) The subjects in different outcome groups are comparable, based on the study design or 
analysis. Confounding factors are controlled. 
a) The study controls for the most important factor (Socio-economic status).  
b) The study control for any additional factor (Gender).  
Outcome: (Maximum 3 stars) 
1) Assessment of the outcome: 
a) Independent blind assessment.  
b) Record linkage.  
c) Self-report.  
d) No description. 
2) Statistical test: 
a) The statistical test used to analyze the data is clearly described and appropriate, and 
the measurement of the association is presented, including confidence intervals and 
the probability level (p value).  
b) The statistical test is not appropriate, not described or incomplete. 
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NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE 
 (adapted for cross sectional studies) 
Reference: (Abou El-Ezz & Ez-Elarab, 2011)     Grade: 5 
Selection: (Maximum 5 stars) 
1) Representativeness of the sample: 
a) Truly representative of the average in the target population.  (all subjects or 
random sampling). 
b) Somewhat representative of the average in the target population.  (non-random 
sampling). 
c) Selected group of users. 
d) No description of the sampling strategy. 
2) Sample size: 
a) Justified and satisfactory.  
b) Not justified. 
3) Non-respondents: 
a) Comparability between respondents and non-respondents’ characteristics is 
established, and the response rate is satisfactory.  
b) The response rate is unsatisfactory, or the comparability between respondents and 
non-respondents is unsatisfactory. 
c) No description of the response rate or the characteristics of the responders and the 
non-responders. 
4) Ascertainment of the exposure (self-medication): 
a) Validated measurement tool.  
b) Non-validated measurement tool, but the tool is available or described.  
c) No description of the measurement tool. 
Comparability: (Maximum 2 stars) 
1) The subjects in different outcome groups are comparable, based on the study design or 
analysis. Confounding factors are controlled. 
a) The study controls for the most important factor (select one).  
b) The study control for any additional factor (Gender).  
Outcome: (Maximum 3 stars) 
1) Assessment of the outcome: 
a) Independent blind assessment.  
b) Record linkage.  
c) Self-report.  
d) No description. 
2) Statistical test: 
a) The statistical test used to analyze the data is clearly described and appropriate, and 
the measurement of the association is presented, including confidence intervals and 
the probability level (p value).  
b) The statistical test is not appropriate, not described or incomplete. 
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NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE 
 (adapted for cross sectional studies) 
Reference: (Dooling, et al., 2014)       Grade: 8 
Selection: (Maximum 5 stars) 
1) Representativeness of the sample: 
a) Truly representative of the average in the target population.  (all subjects or 
random sampling). 
b) Somewhat representative of the average in the target population.  (non-random 
sampling). 
c) Selected group of users. 
d) No description of the sampling strategy. 
2) Sample size: 
a) Justified and satisfactory.  
b) Not justified. 
3) Non-respondents: 
a) Comparability between respondents and non-respondents’ characteristics is 
established, and the response rate is satisfactory.  
b) The response rate is unsatisfactory, or the comparability between respondents and 
non-respondents is unsatisfactory. 
c) No description of the response rate or the characteristics of the responders and the 
non-responders. 
4) Ascertainment of the exposure (self-medication): 
a) Validated measurement tool.  
b) Non-validated measurement tool, but the tool is available or described.  
c) No description of the measurement tool. 
Comparability: (Maximum 2 stars) 
1) The subjects in different outcome groups are comparable, based on the study design or 
analysis. Confounding factors are controlled. 
a) The study controls for the most important factor (Educational level).  
b) The study control for any additional factor (Gender).  
Outcome: (Maximum 3 stars) 
1) Assessment of the outcome: 
a) Independent blind assessment.  
b) Record linkage.  
c) Self-report.  
d) No description. 
2) Statistical test: 
a) The statistical test used to analyze the data is clearly described and appropriate, and 
the measurement of the association is presented, including confidence intervals and 
the probability level (p value).  
b) The statistical test is not appropriate, not described or incomplete. 
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NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE 
 (adapted for cross sectional studies) 
Reference: (Amin, Amine, & Newegy, 2017)     Grade: 7 
Selection: (Maximum 5 stars) 
1) Representativeness of the sample: 
a) Truly representative of the average in the target population.  (all subjects or 
random sampling). 
b) Somewhat representative of the average in the target population.  (non-random 
sampling). 
c) Selected group of users. 
d) No description of the sampling strategy. 
2) Sample size: 
a) Justified and satisfactory.  
b) Not justified. 
3) Non-respondents: 
a) Comparability between respondents and non-respondents’ characteristics is 
established, and the response rate is satisfactory.  
b) The response rate is unsatisfactory, or the comparability between respondents and 
non-respondents is unsatisfactory. 
c) No description of the response rate or the characteristics of the responders and the 
non-responders. 
4) Ascertainment of the exposure (self-medication): 
a) Validated measurement tool.  
b) Non-validated measurement tool, but the tool is available or described.  
c) No description of the measurement tool. 
Comparability: (Maximum 2 stars) 
1) The subjects in different outcome groups are comparable, based on the study design or 
analysis. Confounding factors are controlled. 
a) The study controls for the most important factor (socio-economic status).  
b) The study control for any additional factor.  
Outcome: (Maximum 3 stars) 
1) Assessment of the outcome: 
a) Independent blind assessment.  
b) Record linkage.  
c) Self-report.  
d) No description. 
2) Statistical test: 
a) The statistical test used to analyze the data is clearly described and appropriate, and 
the measurement of the association is presented, including confidence intervals and 
the probability level (p value).  
b) The statistical test is not appropriate, not described or incomplete. 
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NEWCASTLE - OTTAWA QUALITY ASSESSMENT SCALE 
 (adapted for cross sectional studies) 
Reference: (Abdelaziz, et al., 2019)       Grade: 6 
Selection: (Maximum 5 stars) 
1) Representativeness of the sample: 
a) Truly representative of the average in the target population.  (all subjects or 
random sampling). 
b) Somewhat representative of the average in the target population.  (non-random 
sampling). 
c) Selected group of users. 
d) No description of the sampling strategy. 
2) Sample size: 
a) Justified and satisfactory.  
b) Not justified. 
3) Non-respondents: 
a) Comparability between respondents and non-respondents’ characteristics is 
established, and the response rate is satisfactory.  
b) The response rate is unsatisfactory, or the comparability between respondents and 
non-respondents is unsatisfactory. 
c) No description of the response rate or the characteristics of the responders and the 
non-responders. 
4) Ascertainment of the exposure (self-medication): 
a) Validated measurement tool.  
b) Non-validated measurement tool, but the tool is available or described.  
c) No description of the measurement tool. 
Comparability: (Maximum 2 stars) 
1) The subjects in different outcome groups are comparable, based on the study design or 
analysis. Confounding factors are controlled. 
a) The study controls for the most important factor (Education level).  
b) The study control for any additional factor (Gender).  
Outcome: (Maximum 3 stars) 
1) Assessment of the outcome: 
a) Independent blind assessment.  
b) Record linkage.  
c) Self-report.  
d) No description. 
2) Statistical test: 
a) The statistical test used to analyze the data is clearly described and appropriate, and 
the measurement of the association is presented, including confidence intervals and 
the probability level (p value).  
b) The statistical test is not appropriate, not described or incomplete. 
 
Appendix 2. 
55 | P a g e  
 
Example of the used data extraction form 
Reference (Ghazawy, Hassan, Mohamed, & Emam, 2017) 
Author Ghazawy et al. 
Study design Cross-sectional study 
Year of the study 2017 
Study subjects General population 
Settings Participants’ houses 
City Minia 
Sample size 422 Adult respondents (Response rate 91.7%) 
Age range from 18 to 72 years with a mean (34.5 ± 13.4) 
Gender Males 45.7 %, Females 54.3 % 
Level of education 
Lower than High school 14.2 % 
High school or higher 85.8 % 
Method of data 
collection 
Interview questionnaire 
Recall period 1 month 
Source of 
antibiotic 
Private pharmacy 86.7 % 
Leftover prescription medication 79.9 % 





Self-medication with antibiotics was reported by 260 of 422 
respondents (61.6%), 47.3% of which used antibiotics more than once 
during the past month prior to the study. About 64% reported that they 
discontinued medication on improvement. 
Reasons for  
self-medication 
Illness was perceived as minor 59.7 % 
Previous experience with the treatment 40.9 %  
Saving time 29.8 % 
Saving money 25 % 
Quality Score 
(NOS) 
7/10 
 
